Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:35
Natalie’s Everyday Heroes: Camp Caring shows kids how to lend...
-
3:42
‘He had a pure heart’: Fallen MPD Officer Kendall Corder’s...
-
2:20
Before Officer Kendall Corder worked for the Milwaukee Police...
-
1:05
’I believe in the power of this city’: Mayor Johnson kicks...
-
0:53
Mount Pleasant hosts time trials for USA Cycling Masters and...
-
4:57
Fallen Heroes Fund supports families of Milwaukee police officers...
-
1:50
Memorial grows for fallen Officer Corder outside Milwaukee Police...
-
1:27
5 teens charged after fire at former industrial building in Kenosha
-
2:39
Hartford train derailment: 3 injured as crews work to contain...
-
5:44
Racine Zoo previews schedule of July events
-
4:46
Waukesha County Fair expands inclusive fun for 183rd year
-
2:42
Soaking rains on Sunday for some with a few more storms possible...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.